Genome-Wide/NN
Association/NN
Study/NN
of/IN
Bone/NN
Mineral/JJ
Density/NN
in/IN
Korean/JJ
Men/JJ
./.
====================
Osteoporosis/NN
is/VBZ
a/DT
medical/JJ
condition/NN
of/IN
global/JJ
concern/NN
,/,
with/IN
increasing/VBG
incidence/NN
in/IN
both/CC
sexes/NNS
./.
====================
Bone/DT
mineral/JJ
density/NN
(/(
BMD/NN
)/)
,/,
a/DT
highly/RB
heritable/JJ
trait/VBP
,/,
has/VBZ
been/VBN
proven/VBN
a/DT
useful/JJ
diagnostic/JJ
factor/NN
in/IN
predicting/VBG
fracture/NN
./.
====================
Because/IN
medical/JJ
information/NN
is/VBZ
lacking/VBG
about/RB
male/JJ
osteoporotic/JJ
genetics/NNS
,/,
we/PRP
conducted/VBD
a/DT
genome-wide/NN
association/NN
study/NN
of/IN
BMD/NN
in/IN
Korean/JJ
men/NNS
./.
====================
With/IN
1,176/CD
participants/NNS
,/,
we/PRP
analyzed/VBD
4,414,664/CD
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
after/IN
genomic/JJ
imputation/NN
,/,
and/CC
identified/VBD
five/CD
SNPs/NNS
and/CC
three/CD
loci/NNS
correlated/VBD
with/IN
bone/NN
density/NN
and/CC
strength/NN
./.
====================
Multivariate/JJ
linear/JJ
regression/NN
models/NNS
were/VBD
applied/VBN
to/TO
adjust/VB
for/IN
age/NN
and/CC
body/NN
mass/NN
index/NN
interference/NN
./.
====================
Rs17124500/CD
(/(
p/NN
=/JJ
6.42/CD
×/NNP
10-7/CD
)/)
,/,
rs34594869/RB
(/(
p/NN
=/JJ
6.53/CD
×/NNP
10-7/CD
)/)
and/CC
rs17124504/NN
(/(
p/NN
=/JJ
6.53/CD
×/NNP
10-7/CD
)/)
in/IN
14q31.3/CD
and/CC
rs140155614/NN
(/(
p/NN
=/JJ
8.64/CD
×/NNP
10-7/CD
)/)
in/IN
15q25.1/NN
were/VBD
significantly/RB
associated/VBN
with/IN
lumbar/JJ
spine/NN
BMD/NN
(/(
LS-BMD/NN
)/)
,/,
while/IN
rs111822233/CD
(/(
p/NN
=/JJ
6.35/CD
×/NNP
10-7/CD
)/)
was/VBD
linked/VBN
with/IN
the/DT
femur/JJ
total/JJ
BMD/NN
(/(
FT-BMD/NN
)/)
./.
====================
Additionally/RB
,/,
we/PRP
analyzed/VBD
the/DT
relationship/NN
between/IN
BMD/NN
and/CC
five/CD
genes/NNS
previously/RB
identified/VBN
in/IN
Korean/JJ
men/NNS
./.
====================
Rs61382873/NN
(/(
p/NN
=/JJ
0.0009/CD
)/)
in/IN
LRP5/NN
,/,
rs9567003/NN
(/(
p/NN
=/JJ
0.0033/CD
)/)
in/IN
TNFSF11/NN
and/CC
rs9935828/NN
(/(
p/NN
=/JJ
0.0248/CD
)/)
in/IN
FOXL1/NN
were/VBD
observed/VBN
for/IN
LS-BMD/NN
./.
====================
Furthermore/RB
,/,
rs33997547/NN
(/(
p/NN
=/JJ
0.0057/CD
)/)
in/IN
ZBTB/NN
and/CC
rs1664496/NN
(/(
p/NN
=/JJ
0.0012/CD
)/)
in/IN
MEF2C/NN
were/VBD
found/VBN
to/TO
influence/VB
FT-BMD/NN
and/CC
rs61769193/NN
(/(
p/NN
=/JJ
0.0114/CD
)/)
in/IN
ZBTB/NN
to/TO
influence/VB
femur/JJ
neck/NN
BMD/NN
./.
====================
We/PRP
identified/VBD
five/CD
SNPs/NNS
and/CC
three/CD
genomic/JJ
regions/NNS
,/,
associated/VBN
with/IN
BMD/NN
./.
====================
The/DT
significance/NN
of/IN
our/PRP$
results/NNS
lies/VBZ
in/IN
the/DT
discovery/NN
of/IN
new/JJ
loci/NNS
,/,
while/IN
also/RB
affirming/VBG
a/DT
previously/RB
significant/JJ
locus/NN
,/,
as/IN
potential/JJ
osteoporotic/JJ
factors/NNS
in/IN
the/DT
Korean/JJ
male/JJ
population/NN
./.
====================
Osteoporosis/NN
is/VBZ
defined/VBN
as/IN
a/DT
chronic/JJ
condition/NN
that/DT
is/VBZ
characterized/VBN
by/IN
low/JJ
bone/NN
mass/NN
and/CC
the/DT
micro-architectural/JJ
deterioration/NN
of/IN
osseous/JJ
tissue/NN
,/,
leading/VBG
to/TO
fragility/NN
./.
====================
Bone/DT
mineral/JJ
density/NN
(/(
BMD/NN
)/)
has/VBZ
been/VBN
established/VBN
as/IN
the/DT
most/JJS
significant/JJ
diagnostic/JJ
factor/NN
for/IN
osteoporotic/JJ
fracture/NN
[/(
12/CD
]/)
./.
====================
Although/IN
more/RBR
widespread/JJ
in/IN
women/NNS
,/,
about/RB
1.5/CD
million/NN
males/NNS
over/IN
the/DT
age/NN
of/IN
65/CD
have/VBP
osteoporosis/NN
and/CC
another/DT
3.5/CD
million/NN
are/VBP
at/IN
risk/NN
in/IN
the/DT
United/JJ
States/NNS
[/(
3/CD
]/)
./.
====================
Among/IN
Korean/JJ
men/NNS
,/,
the/DT
prevalence/NN
of/IN
the/DT
condition/NN
has/VBZ
also/RB
increased/VBD
by/IN
about/RB
7.5/CD
%/NN
,/,
according/VBG
to/TO
national/JJ
health/NN
survey/NN
data/NNS
[/(
4/CD
]/)
./.
====================
Major/JJ
risk/NN
factors/NNS
of/IN
male/JJ
osteoporosis/NN
are/VBP
aging/NN
and/CC
lifestyle/JJ
choices/NNS
,/,
such/JJ
as/IN
smoking/NN
,/,
alcohol/NN
,/,
and/CC
lack/NN
of/IN
exercise/NN
[/(
567/CD
]/)
./.
====================
Genetic/JJ
factors/NNS
may/MD
also/RB
play/VBP
a/DT
significant/JJ
role/NN
,/,
because/IN
BMD/NN
has/VBZ
been/VBN
observed/VBN
to/TO
have/VB
similar/JJ
heritability/NN
patterns/NNS
in/IN
both/DT
men/NNS
and/CC
women/NNS
[/(
8/CD
]/)
./.
====================
Thought/DT
to/TO
be/VB
heritable/JJ
,/,
BMD/NN
is/VBZ
78/CD
%/NN
in/IN
the/DT
lumbar/JJ
spine/NN
and/CC
84/CD
%/NN
in/IN
the/DT
femoral/JJ
neck/NN
[/(
9/CD
]/)
./.
====================
Up/IN
to/TO
100/CD
genes/NNS
,/,
associated/VBN
with/IN
BMD/NN
,/,
have/VBP
been/VBN
identified/VBN
to/TO
date/NN
by/IN
various/JJ
genetic/JJ
studies/NNS
[/(
1011/CD
]/)
./.
====================
One/CD
current/JJ
meta-analysis/NN
identified/VBN
56/CD
loci/NNS
including/VBG
32/CD
new/JJ
regions/NNS
associated/VBN
with/IN
BMD/NN
with/IN
highly/RB
significant/JJ
level/NN
[/(
12/CD
]/)
./.
====================
The/DT
study/NN
had/VBD
demonstrated/VBN
several/JJ
genetic/JJ
loci/NNS
such/JJ
as/IN
myocyte/JJ
enhancer/NN
factor/NN
2C/NN
(/(
MEF2C/NNS
)/)
,/,
zinc/NN
finger-/NN
and/CC
BTB-domain/NN
containing/VBG
40/CD
(/(
ZBTB40/CD
)/)
,/,
low-density/JJ
lipoprotein/NN
receptor-related/JJ
protein/NN
5/CD
(/(
LRP5/NNP
)/)
,/,
and/CC
forkhead/RB
box/NN
L1/NN
(/(
FOXL1/NN
)/)
which/WDT
have/VBP
been/VBN
significantly/RB
replicated/VBN
in/IN
Korean/JJ
population/NN
in/IN
later/JJ
studies/NNS
[/(
1314/CD
]/)
./.
====================
However/RB
,/,
the/DT
influence/NN
of/IN
sex-specific/JJ
genes/NNS
remains/VBZ
unclear/JJ
,/,
because/IN
most/JJS
of/IN
the/DT
research/NN
has/VBZ
been/VBN
conducted/VBN
on/IN
highly/RB
homogeneous/JJ
population/NN
samples/NNS
,/,
mostly/RB
European/NN
post-menopausal/JJ
women/NNS
[/(
11/CD
]/)
./.
====================
Several/JJ
investigations/NNS
of/IN
genetic/JJ
components/NNS
in/IN
male/JJ
osteoporosis/NN
are/VBP
available/JJ
,/,
but/CC
they/PRP
rely/RB
on/IN
candidate/NN
data/NNS
or/CC
produced/VBN
no/DT
significant/JJ
results/NNS
[/(
15/CD
]/)
./.
====================
Moreover/RB
,/,
cases/NNS
of/IN
East/JJ
Asian/JJ
populations/NNS
as/IN
the/DT
participating/VBG
demographic/JJ
are/VBP
largely/RB
absent/JJ
from/IN
the/DT
literature/NN
or/CC
consist/VB
of/IN
replications/NNS
and/CC
attempts/NNS
to/TO
confirm/VB
results/NNS
already/RB
derived/VBN
from/IN
Caucasian/JJ
samples/NNS
[/(
131416/CD
]/)
./.
====================
A/DT
recent/JJ
study/NN
of/IN
a/DT
Korean/JJ
group/NN
was/VBD
able/JJ
to/TO
newly/RB
identify/VBP
several/JJ
polymorphic/JJ
factors/NNS
,/,
but/CC
unfortunately/RB
,/,
it/PRP
utilized/VBD
BMD/NN
from/IN
the/DT
radius/JJ
and/CC
tibia/NN
,/,
which/WDT
is/VBZ
less/RBR
important/JJ
in/IN
the/DT
development/NN
of/IN
bone/NN
deterioration/NN
than/IN
that/DT
of/IN
the/DT
lumbar/JJ
spine/NN
and/CC
hip/NN
bone/NN
[/(
17/CD
]/)
./.
====================
Investigating/VBG
the/DT
etiology/NN
behind/VBP
osteoporosis/NN
in/IN
males/NNS
of/IN
East/JJ
Asian/JJ
descent/JJ
is/VBZ
of/IN
high/JJ
diagnostic/JJ
and/CC
clinical/JJ
importance/NN
./.
====================
Therefore/RB
,/,
our/PRP$
study/NN
aimed/VBD
to/TO
evaluate/VB
the/DT
role/NN
of/IN
genetic/JJ
polymorphisms/NNS
in/IN
forming/VBG
the/DT
BMD/NN
at/IN
the/DT
lumbar/JJ
spine/NN
and/CC
femur/JJ
bone/NN
in/IN
Korean/JJ
men/NNS
./.
====================
Study/NN
populations/NNS
====================
We/PRP
selected/VBD
non-osteoporotic/JJ
participants/NNS
who/WP
were/VBD
tested/VBN
via/IN
dual-energy/JJ
X-ray/NN
absorptiometry/NN
from/IN
the/DT
Center/JJ
for/IN
Health/NN
Promotion/NN
and/CC
Disease/NN
Prevention/NN
of/IN
Seoul/JJ
National/JJ
University/NN
Hospital/JJ
and/CC
the/DT
Gangnam/JJ
Center/NN
for/IN
Health/NN
Promotion/NN
./.
====================
The/DT
subjects/NNS
underwent/JJ
regular/JJ
health/NN
check-ups/NNS
from/IN
May/NN
2009/CD
to/TO
December/NN
2013/CD
./.
====================
Our/PRP$
sample/NN
consisted/VBD
exclusively/RB
of/IN
Korean/JJ
men/NNS
aged/JJ
between/IN
20/CD
and/CC
60/CD
years/NNS
./.
====================
This/DT
initial/JJ
step/NN
of/IN
the/DT
procedure/NN
was/VBD
performed/VBN
to/TO
detect/VB
genetic/JJ
defects/NNS
associated/VBN
with/IN
obesity/NN
and/CC
metabolic/JJ
syndrome/NN
[/(
1819/CD
]/)
./.
====================
Those/DT
with/IN
conditions/NNS
that/WDT
could/MD
affect/VB
body/NN
weight/NN
were/VBD
excluded/VBN
from/IN
the/DT
study/NN
./.
====================
We/PRP
also/RB
excluded/VBN
individuals/NNS
who/WP
had/VBD
taken/VBN
any/DT
medication/NN
that/DT
might/MD
influence/VB
BMD/NN
,/,
such/JJ
as/IN
bisphosphonate/JJ
,/,
within/IN
the/DT
last/JJ
3/CD
months/NNS
or/CC
had/VBD
a/DT
history/JJ
of/IN
surgery/NN
or/CC
foreign/JJ
body/NN
insertion/NN
at/IN
the/DT
spine/NN
or/CC
femur/JJ
./.
====================
After/IN
applying/VBG
the/DT
above/JJ
criteria/NNS
,/,
1,192/CD
subjects/NNS
were/VBD
selected/VBN
./.
====================
After/IN
excluding/VBG
16/CD
participants/NNS
who/WP
were/VBD
related/JJ
to/TO
each/DT
other/JJ
,/,
our/PRP$
final/JJ
sample/NN
consisted/VBD
of/IN
1,176/CD
individuals/NNS
./.
====================
Phenotype/NN
measurement/NN
====================
Dual-energy/NN
X-ray/NN
absorptiometry/NN
(/(
Prodigy/NN
Advance/NN
;/:
General/JJ
Electric/JJ
Company/JJ
,/,
Fairfield/JJ
,/,
CT/NN
,/,
USA/NNP
)/)
measurements/NNS
at/IN
the/DT
lumbar/JJ
spine/NN
and/CC
femur/JJ
were/VBD
obtained/VBN
from/IN
all/DT
patients/NNS
,/,
following/VBG
standard/JJ
protocols/NNS
./.
====================
We/PRP
distinguished/VBD
and/CC
analyzed/VBD
three/CD
BMD/NN
phenotypes—lumbar/JJ
spine/NN
(/(
L1-L4/NN
)/)
(/(
LS-BMD/NN
)/)
,/,
femur/JJ
neck/NN
(/(
FN-BMD/NN
)/)
,/,
and/CC
femur/JJ
total/JJ
(/(
FT-BMD/NN
)/)
—identified/VBD
here/RB
as/IN
the/DT
average/NN
value/NN
of/IN
mineral/JJ
density/NN
at/IN
the/DT
neck/NN
and/CC
greater/JJR
trochanter/NN
of/IN
the/DT
femur/JJ
bone/NN
./.
====================
Genotyping/VBG
and/CC
quality/NN
control/NN
====================
All/DT
participants/NNS
underwent/JJ
a/DT
microarray/NN
assay/NN
,/,
using/VBG
the/DT
Illunina/NN
HumanCore/RBR
BeadChip/NN
kit/NN
(/(
Illumina/NN
,/,
San/JJ
Diego/NN
,/,
CA/NN
,/,
USA/NN
)/)
./.
====================
We/PRP
filtered/VBD
out/IN
poor/JJ
quality/NN
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
and/CC
samples/NNS
,/,
which/WDT
were/VBD
defined/VBN
as/IN
SNPs/NNS
with/IN
a/DT
monographic/JJ
genotype/NN
,/,
a/DT
Hardy-Weinberg/JJ
equilibrium/NN
p/NN
</JJR
10-6/CD
,/,
a/DT
call/JJ
rate/NN
</JJR
95/CD
%/NN
,/,
and/CC
a/DT
minor/JJ
allele/NN
frequency/NN
</JJR
1/CD
%/NN
./.
====================
After/IN
quality/NN
control/NN
,/,
the/DT
remaining/VBG
264,283/CD
SNPs/NNS
were/VBD
used/VBN
in/IN
subsequent/JJ
analysis/NN
./.
====================
Genotype/NN
imputation/NN
====================
All/DT
missing/VBG
genotypes/NNS
were/VBD
imputed/VBN
in/IN
order/NN
to/TO
examine/VB
any/DT
potential/JJ
effect/NN
of/IN
the/DT
unmeasured/JJ
variants/NNS
./.
====================
We/PRP
used/VBD
1,000/CD
Genomes/NNS
ASN/JJ
Phase/NN
I/NN
integrated/VBD
variant/JJ
set/NN
release/NN
(/(
v3/RB
)/)
in/IN
National/JJ
Center/JJ
for/IN
Biotechnology/NN
Information/NN
(/(
NCBI/NNP
)/)
build/JJ
37/CD
(/(
hg19/CD
)/)
as/IN
a/DT
reference/RB
panel/NN
,/,
along/IN
with/IN
PLINK/NN
software/RB
(/(
version/NN
1.07/CD
)/)
[/(
20/CD
]/)
for/IN
strand/NN
alignment/NN
,/,
SHAPEIT2/NN
[/(
21/CD
]/)
for/IN
phasing/VBG
,/,
and/CC
IMPUTE2/NN
[/(
22/CD
]/)
for/IN
the/DT
imputation/NN
procedure/NN
./.
====================
Only/RB
variants/NNS
with/IN
Info/NN
Score/NNP
≥0.9/CD
were/VBD
included/VBN
in/IN
the/DT
final/JJ
count/NN
,/,
resulting/VBG
in/IN
a/DT
total/JJ
of/IN
4,414,664/CD
SNPs/NNS
,/,
which/WDT
were/VBD
either/CC
genotyped/VBN
or/CC
imputed/JJ
with/IN
high/JJ
confidence/NN
./.
====================
Statistical/JJ
analyses/NNS
====================
Multivariate/JJ
linear/JJ
regressions/NNS
,/,
adjusted/VBN
for/IN
the/DT
effects/NNS
of/IN
age/NN
and/CC
body/NN
mass/NN
index/NN
(/(
BMI/NN
,/,
weight/height2/NN
,/,
kg/m2/NN
)/)
[/(
23/CD
]/)
via/IN
an/DT
additive/JJ
model/NN
,/,
were/VBD
used/VBN
to/TO
further/RBR
investigate/VB
the/DT
influence/NN
of/IN
SNPs/NNS
on/IN
BMD/NN
./.
====================
Genome-wide/NN
association/NN
patterns/NNS
were/VBD
analyzed/VBN
by/IN
the/DT
PLINK/NN
software/RB
package/NN
version/NN
1.07/CD
[/(
20/CD
]/)
,/,
while/IN
quantile-quantile/RB
and/CC
Manhattan/JJ
plots/NNS
were/VBD
obtained/VBN
by/IN
R/NN
software/RB
3.2.2/CD
(/(
2015/CD
The/DT
R/NN
Foundation/NN
for/IN
Statistical/JJ
Computing/JJ
)/)
./.
====================
Regional/JJ
association/NN
plots/NNS
of/IN
the/DT
significant/JJ
SNPs/NNS
were/VBD
generated/VBN
by/IN
LocusZoom/JJ
software/JJ
[/(
24/CD
]/)
./.
====================
All/DT
results/NNS
with/IN
p/NN
</JJR
1/CD
×/NN
10-6/CD
were/VBD
considered/VBN
statistically/RB
significant/JJ
./.
====================
Association/NN
with/IN
previously/RB
identified/VBN
loci/NNS
====================
We/PRP
attempted/VBD
to/TO
determine/VB
similarities/NNS
between/IN
our/PRP$
selected/VBN
markers/NNS
and/CC
five/CD
other/JJ
genes/NNS
,/,
which/WDT
have/VBP
previously/RB
been/VBN
identified/VBN
as/IN
indicative/JJ
of/IN
osteoporosis/NN
in/IN
Korean/JJ
male/JJ
populations/NNS
./.
====================
Tumor/NN
necrosis/NN
factor/NN
receptor/NN
superfamily/NN
member/NN
11/CD
(/(
TNFSF11/NN
)/)
on/IN
13q14/NN
,/,
FOXL1/NN
on/IN
16q24/NN
,/,
LRP5/NNP
on/IN
11q13.4/CD
,/,
ZBTB40/CD
on/IN
1q31.3/CD
,/,
and/CC
MEF2C/NN
on/IN
5q14/NN
have/VBP
been/VBN
connected/VBN
to/TO
BMD/NN
in/IN
several/JJ
different/JJ
genome-wide/NN
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
—an/JJ
association/NN
confirmed/VBD
in/IN
Korean/JJ
males/NNS
by/IN
a/DT
number/NN
of/IN
replication/NN
studies/NNS
[/(
1314/CD
]/)
./.
====================
We/PRP
examined/VBD
the/DT
most/JJS
significant/JJ
SNP/NN
regions/NNS
of/IN
these/DT
five/CD
genes/NNS
by/IN
applying/VBG
our/PRP$
markers/NNS
and/CC
considering/VBG
only/RB
results/VBZ
with/IN
a/DT
p/NN
</JJR
0.05/CD
./.
====================
Ethics/NNS
statement/JJ
====================
The/DT
study/NN
protocol/NN
was/VBD
approved/VBN
by/IN
the/DT
Institutional/JJ
Review/NN
Board/JJ
at/IN
Seoul/JJ
National/JJ
University/NN
Hospital/JJ
(/(
IRB/NN
No/DT
./.
====================
H-0911-010-299/NN
)/)
and/CC
all/DT
participants/NNS
provided/VBD
written/CD
informed/VBN
consent/NN
./.
====================
The/DT
mean/JJ
age/NN
of/IN
the/DT
study/NN
subjects/NNS
was/VBD
49.57/CD
years/NNS
,/,
with/IN
BMI/NN
values/NNS
between/IN
16.58/CD
kg/m2/NN
and/CC
37.27/CD
kg/m2/NN
./.
====================
We/PRP
examined/VBD
distribution/NN
patterns/NNS
of/IN
three/CD
BMD/NN
phenotypes/NNS
:/:
LS-BMD/NN
,/,
FN-BMD/NN
,/,
and/CC
FT-BMD/NN
./.
====================
LS-BMD/NN
ranged/VBD
between/IN
0.78/CD
g/cm2/NN
and/CC
1.84/CD
g/cm2/NN
(/(
mean/JJ
±/CD
SD/NN
,/,
1.21/CD
±/CD
0.38/CD
g/cm2/NN
)/)
,/,
FN-BMD/NN
ranged/VBD
between/IN
0.64/CD
g/cm2/NN
and/CC
1.93/CD
g/cm2/NN
(/(
mean/JJ
±/CD
SD/NN
,/,
0.98/CD
±/CD
0.14/CD
g/cm2/NN
)/)
,/,
and/CC
FT-BMD/NN
ranged/VBD
between/IN
0.29/CD
g/cm2/NN
and/CC
1.93/CD
g/cm2/NN
(/(
mean/JJ
±/CD
SD/NN
,/,
1.04/CD
±/CD
0.14/CD
g/cm2/NN
)/)
(/(
Table/JJ
1/CD
)/)
./.
====================
We/PRP
identified/VBD
five/CD
SNPs/NNS
with/IN
a/DT
significant/JJ
influence/NN
on/IN
BMD/NN
./.
====================
Rs17124500/CD
(/(
p/NN
=/JJ
6.42/CD
×/CD
10-7/CD
)/)
,/,
rs34594869/CD
(/(
p/NN
=/JJ
6.53/CD
×/CD
10-7/CD
)/)
,/,
rs17124504/NN
(/(
p/NN
=/JJ
6.53/CD
×/CD
10-7/CD
)/)
,/,
and/CC
rs140155614/NN
(/(
p/NN
=/JJ
8.64/CD
×/CD
10-7/CD
)/)
were/VBD
significantly/RB
associated/VBN
with/IN
LS-BMD/NN
,/,
and/CC
rs111822233/CD
(/(
p/NN
=/JJ
6.35/CD
×/CD
10-7/CD
)/)
was/VBD
associated/VBN
with/IN
FT-BMD/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
Fig/NN
./.
====================
1/CD
illustrates/VBZ
regional/JJ
plots/NNS
of/IN
the/DT
five/CD
significant/JJ
SNPs/NNS
within/IN
200/CD
kilobytes/NNS
./.
====================
No/DT
genomic/JJ
association/NN
between/IN
FN-BMD/NN
and/CC
any/DT
polymorphic/JJ
nucleotides/NNS
was/VBD
established/VBN
./.
====================
Quantile–quantile/JJ
and/CC
Manhattan/JJ
plots/NNS
of/IN
the/DT
p-values/NNS
are/VBP
shown/VBN
in/IN
Supplementary/JJ
Figs/NNS
./.
====================
1/CD
and/CC
2/CD
./.
====================
Examination/NN
of/IN
genomic/JJ
location/NN
revealed/VBD
that/IN
rs17124500/CD
,/,
which/WDT
was/VBD
the/DT
polymorphic/JJ
nucleotide/NN
most/JJS
closely/RB
associated/VBN
with/IN
LS-BMD/NN
,/,
is/VBZ
generally/RB
detected/VBN
in/IN
potassium/NN
channel/NN
,/,
subfamily/RB
K/NN
,/,
member/NN
1/CD
(/(
KCNK10/CD
)/)
in/IN
14q31.3/CD
(/(
Fig/NN
./.
====================
1A/NN
)/)
./.
====================
Rs34594869/CD
and/CC
rs17124504/NN
,/,
were/VBD
observed/VBN
upstream/RB
of/IN
regions/NNS
with/IN
high/JJ
linkage/NN
disequilibrium/NN
constants/NNS
,/,
defined/VBN
here/RB
as/IN
D/NN
'/``
>/JJR
0.8/CD
./.
====================
Rs140155614/NN
was/VBD
most/RBS
prominent/JJ
in/IN
the/DT
aminoglycoside/NN
phosphotransferase/NN
domain/NN
containing/VBG
1/CD
(/(
AGPHD1/NN
)/)
locus/NN
15q25.1/NN
(/(
Fig/NN
./.
====================
1B/NN
)/)
./.
====================
All/DT
four/CD
of/IN
these/DT
SNPs/NNS
occurred/VBD
as/IN
intron/NN
variants/NNS
./.
====================
rs111822233/CD
,/,
the/DT
only/RB
sequence/NN
to/TO
influence/VB
the/DT
mineral/JJ
density/NN
of/IN
the/DT
femur/JJ
total/JJ
,/,
was/VBD
positioned/VBN
around/IN
the/DT
nuclear/JJ
receptor/NN
subfamily/NN
3/CD
,/,
group/NN
C/NN
,/,
member/NN
2/CD
(/(
NR3C2/NN
)/)
in/IN
4q31.1/NN
(/(
Fig/NN
./.
====================
1C/NN
)/)
./.
====================
The/DT
function/NN
of/IN
this/DT
SNP/NN
is/VBZ
currently/RB
undetermined/VBN
./.
====================
In/IN
addition/NN
to/TO
establishing/VBG
links/NNS
between/IN
genetic/JJ
polymorphisms/NNS
and/CC
BMD/NN
,/,
our/PRP$
studies/NNS
aimed/VBD
to/TO
identify/VB
loci/NNS
previously/RB
confirmed/VBD
as/IN
osteoporosis/NN
factors/NNS
in/IN
Korean/JJ
male/JJ
populations/NNS
in/IN
order/NN
to/TO
verify/VB
our/PRP$
outcomes/NNS
(/(
Table/JJ
3/CD
)/)
./.
====================
Rs61382873/NN
in/IN
LRP5/NN
exhibited/VBD
the/DT
highest/JJS
association/NN
with/IN
LS-BMD/NN
(/(
p/NN
=/JJ
0.0009/CD
)/)
./.
====================
Rs9567003/NN
(/(
p/NN
=/JJ
0.0033/CD
)/)
in/IN
TNFSF11/NN
and/CC
rs9935828/NN
(/(
p/NN
=/JJ
0.0248/CD
)/)
in/IN
FOXL1/NN
were/VBD
also/RB
linked/VBN
to/TO
the/DT
lumbar/JJ
spine/NN
region/NN
,/,
albeit/IN
with/IN
higher/JJR
p-values/NNS
./.
====================
Patterns/NNS
of/IN
rs33997547/NN
(/(
p/NN
=/JJ
0.0057/CD
)/)
in/IN
ZBTB/NN
and/CC
rs1664496/NN
(/(
p/NN
=/JJ
0.0012/CD
)/)
in/IN
MEF2C/NN
were/VBD
correlated/VBN
with/IN
FT-BMD/NN
,/,
while/IN
rs61769193/NN
(/(
p/NN
=/JJ
0.0114/CD
)/)
in/IN
ZBTB/NN
was/VBD
found/VBN
to/TO
influence/VB
FN-BMD/NN
./.
====================
We/PRP
identified/VBD
five/CD
SNPs/NNS
and/CC
three/CD
genomic/JJ
regions/NNS
,/,
associated/VBN
with/IN
BMD/NN
./.
====================
Four/CD
of/IN
these/DT
SNPs/NNS
(/(
rs17124500/CD
,/,
rs34594869/NN
,/,
rs17124504/NN
,/,
and/CC
rs140155614/NN
)/)
were/VBD
linked/VBN
with/IN
LS-BMD/NN
and/CC
dispersed/JJ
between/IN
two/CD
loci/NNS
(/(
14q31.1/NN
and/CC
15q25.1/NN
)/)
./.
====================
One/CD
SNP/NN
(/(
rs111822233/CD
)/)
found/VBD
in/IN
4q31.1/NN
was/VBD
exclusively/RB
associated/VBN
with/IN
FT-BMD/NN
./.
====================
We/PRP
also/RB
re-evaluated/VBD
three/CD
previously/RB
established/VBN
genetic/JJ
relationships/NNS
./.
====================
First/RB
,/,
we/PRP
confirmed/VBD
the/DT
connection/NN
between/IN
LS-BMD/NN
and/CC
the/DT
following/VBG
loci/NNS
:/:
rs61382873/NN
in/IN
LRP5/NN
,/,
rs9567003/NN
in/IN
TNFSF11/NN
,/,
and/CC
rs9935828/NN
in/IN
FOXL1/NN
./.
====================
Next/RB
,/,
we/PRP
linked/VBD
rs33997547/NN
in/IN
ZBTB40/CD
and/CC
rs1664496/NN
in/IN
MEF2C/NN
with/IN
FT-BMD/NN
and/CC
analyzed/VBD
rs61769193/NN
expression/NN
patterns/NNS
in/IN
FN-BMD/NN
./.
====================
Three/CD
of/IN
our/PRP$
significant/JJ
markers—rs17124500/NN
,/,
rs34594869/NN
,/,
and/CC
rs17124504—were/VBP
located/JJ
on/IN
the/DT
KCNK10/NN
gene/NN
./.
====================
This/DT
channel/NN
protein/NN
,/,
embedded/JJ
in/IN
the/DT
cellular/JJ
membrane/NN
,/,
consists/VBZ
of/IN
two/CD
pore-forming/VBG
P/NN
domains/NNS
and/CC
regulates/VBZ
K+/JJ
concentration/NN
./.
====================
The/DT
role/NN
of/IN
potassium/NN
ions/NNS
in/IN
maintaining/VBG
the/DT
acid-base/NN
homeostasis/NN
of/IN
most/JJS
organs/NNS
and/CC
tissues/NNS
,/,
including/VBG
bones/NNS
,/,
has/VBZ
been/VBN
well/RB
established/VBN
in/IN
the/DT
literature/NN
[/(
25/CD
]/)
./.
====================
Additionally/RB
,/,
KCNK10/NN
is/VBZ
located/JJ
on/IN
14q31/NN
,/,
a/DT
locus/NN
previously/RB
associated/VBN
with/IN
LS-BMD/NN
in/IN
linkage/NN
analyses/NNS
[/(
26/CD
]/)
./.
====================
Although/IN
the/DT
relationship/NN
between/IN
the/DT
gene/NN
and/CC
osseous/JJ
metabolism/NN
is/VBZ
not/RB
clear/JJ
,/,
it/PRP
is/VBZ
highly/RB
possible/JJ
that/IN
its/PRP$
translational/JJ
mechanisms/NNS
influence/VBP
bone/NN
biological/JJ
parameters/NNS
./.
====================
rs140155614/NN
was/VBD
prominent/JJ
in/IN
the/DT
AGPHD1/NN
domain/NN
./.
====================
Alternatively/RB
known/VBN
as/IN
hydroxylysine/NN
kinase/NN
(/(
HYKK/NN
)/)
,/,
this/DT
protein-coding/VBG
gene/NN
and/CC
its/PRP$
associated/VBN
pathway/NN
,/,
catalyze/VBP
the/DT
GTP-dependent/JJ
phosphorylation/NN
of/IN
5-hydroxy-L-lysine/JJ
./.
====================
Located/JJ
on/IN
15q25.1/NN
,/,
it/PRP
has/VBZ
a/DT
well-known/JJ
connection/NN
to/TO
the/DT
development/NN
of/IN
lung/NN
cancer/NN
./.
====================
CHRNA3-CHRNA5-CHRNB4/NN
,/,
a/DT
gene/NN
complex/NN
near/JJ
AGPHD1/NN
,/,
has/VBZ
been/VBN
linked/VBN
to/TO
nicotine/NN
dependence/NN
in/IN
several/JJ
genetic/JJ
studies/NNS
[/(
27/CD
]/)
./.
====================
Current/JJ
scientific/JJ
evidence/NN
is/VBZ
insufficient/JJ
in/IN
determining/VBG
the/DT
role/NN
of/IN
this/DT
locus/NN
in/IN
BMD/NN
development/NN
's/POS
replication/NN
patterns/NNS
is/VBZ
needed/VBN
to/TO
validate/VB
or/CC
dispute/JJ
a/DT
relationship/NN
with/IN
BMD/NN
./.
====================
rs111822233/CD
was/VBD
the/DT
only/RB
genetic/JJ
marker/NN
with/IN
a/DT
direct/JJ
relationship/NN
to/TO
FT-BMD/NN
levels/NNS
./.
====================
Located/JJ
on/IN
4q31.1/NN
,/,
it/PRP
is/VBZ
near/JJ
NR3C2/NN
,/,
a/DT
nuclear/JJ
receptor/NN
involved/VBN
in/IN
steroid/NN
signaling/NN
and/CC
regulation/NN
./.
====================
Mineralocorticoid/NN
and/CC
various/JJ
sex/NN
hormones/NNS
,/,
such/JJ
as/IN
testosterone/NN
and/CC
estradiol/NN
,/,
alternatively/RB
bind/VBP
to/TO
the/DT
protein/NN
,/,
which/WDT
influences/VBZ
their/PRP$
secretion/NN
via/IN
a/DT
feedback/NN
loop/NN
[/(
28/CD
]/)
./.
====================
Bone/NN
resorption/NN
has/VBZ
been/VBN
reported/VBN
to/TO
increase/VB
with/IN
the/DT
withdrawal/NN
of/IN
these/DT
sex/NN
hormones/NNS
./.
====================
Although/IN
estrogen/NN
is/VBZ
the/DT
major/JJ
steroid/NN
in/IN
regulating/VBG
ossein/JJ
metabolism/NN
,/,
testosterone/NN
is/VBZ
also/RB
important/JJ
in/IN
the/DT
resorption/NN
mechanism/NN
[/(
29/CD
]/)
./.
====================
Moreover/RB
,/,
prevalence/NN
of/IN
osteoporosis/NN
in/IN
the/DT
hipbone/NN
has/VBZ
been/VBN
shown/VBN
to/TO
increase/VB
in/IN
men/NNS
whose/WP$
testosterone/NN
levels/NNS
are/VBP
lower/JJR
than/IN
the/DT
reference/NN
range/NN
[/(
30/CD
]/)
./.
====================
As/IN
established/VBN
in/IN
our/PRP$
introduction/NN
,/,
research/NN
conducted/VBN
with/IN
Korean/JJ
participants/NNS
tends/NNS
to/TO
be/VB
inconclusive/JJ
owing/VBG
to/TO
extensive/JJ
focus/NN
on/IN
replication/NN
of/IN
results/NNS
obtained/VBN
by/IN
the/DT
original/JJ
GWASs/NNS
./.
====================
Thus/RB
,/,
we/PRP
attempted/VBD
to/TO
bridge/VB
this/DT
gap/NN
in/IN
information/NN
by/IN
validating/VBG
previously/RB
established/VBN
genetic/JJ
linkages/NNS
in/IN
Caucasian/JJ
populations/NNS
,/,
whose/WP$
significance/NN
has/VBZ
been/VBN
confirmed/VBN
in/IN
Korean/JJ
men/NNS
by/IN
replication/NN
studies/NNS
[/(
1314/CD
]/)
./.
====================
LRP5/NN
,/,
MEF2C/NN
,/,
and/CC
ZBTB40/NN
belong/IN
to/TO
the/DT
Wnt/NN
signaling/NN
pathway/NN
,/,
which/WDT
is/VBZ
largely/RB
related/JJ
to/TO
cellular/JJ
development/NN
and/CC
growth/NN
./.
====================
Several/JJ
studies/NNS
have/VBP
observed/VBN
a/DT
link/NN
between/IN
this/DT
cascade/NN
and/CC
BMD/NN
[/(
31/CD
]/)
./.
====================
We/PRP
utilized/VBD
a/DT
series/NN
of/IN
SNP/NN
markers/NNS
from/IN
various/JJ
Wnt-associated/JJ
genes/NNS
and/CC
were/VBD
able/JJ
to/TO
prove/VB
as/IN
association/NN
between/IN
rs61382873/NN
in/IN
LRP5/NN
and/CC
LS-BMD/NN
,/,
between/IN
rs33997547/NN
in/IN
ZBTB40/CD
and/CC
rs1664496/NN
in/IN
MEF2C/NN
and/CC
FT-BMD/NN
,/,
and/CC
between/IN
rs61769193/NN
in/IN
ZBTB40/CD
and/CC
FN-BMD/NN
./.
====================
TNFSF11/NN
,/,
also/RB
known/VBN
as/IN
receptor/NN
activator/NN
of/IN
nuclear/JJ
factor/NN
kappa-B/NN
ligand/NN
(/(
RANKL/NN
)/)
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
adequate/JJ
bone/NN
metabolism/NN
via/IN
activation/NN
of/IN
osteoclast/JJ
cells/NNS
to/TO
regulate/VB
resorption/NN
[/(
31/CD
]/)
./.
====================
We/PRP
identified/VBD
a/DT
significant/JJ
SNP/NN
marker/NN
in/IN
TNFSF11/NN
,/,
rs9567003/NN
,/,
which/WDT
was/VBD
related/JJ
to/TO
LS-BMD/NN
./.
====================
Our/PRP$
results/NNS
were/VBD
consistent/JJ
with/IN
those/DT
of/IN
a/DT
previous/JJ
genetic/JJ
research/NN
,/,
which/WDT
has/VBZ
established/VBN
a/DT
connection/NN
between/IN
TNFSF11/NN
and/CC
BMD/NN
of/IN
the/DT
lumbar/JJ
spinal/JJ
cord/NN
[/(
31/CD
]/)
./.
====================
FOXL1/NN
was/VBD
originally/RB
identified/VBN
by/IN
Genetic/JJ
Factors/NNS
for/IN
Osteoporosis/NN
(/(
GEFOS/NNS
)/)
and/CC
has/VBZ
been/VBN
associated/VBN
with/IN
LS-BMD/NN
in/IN
European/JJ
sample/NN
groups/NNS
;/:
this/DT
result/NN
has/VBZ
been/VBN
replicated/VBN
with/IN
high/JJ
significance/NN
in/IN
Korean/JJ
populations/NNS
[/(
13/CD
]/)
./.
====================
Our/PRP$
marker/NN
in/IN
FOXL1/NN
,/,
rs9935828/NN
,/,
was/VBD
also/RB
correlated/VBD
with/IN
LS-BMD/NN
levels/NNS
./.
====================
In/IN
conclusion/NN
,/,
we/PRP
described/VBD
a/DT
series/NN
of/IN
new/JJ
loci/NNS
and/CC
confirmed/VBD
GWAS/NN
results/NNS
in/IN
Korean/JJ
male/JJ
populations/NNS
by/IN
working/VBG
with/IN
skeletal-specific/JJ
BMD/NN
and/CC
gene/NN
associations/NNS
./.
====================
There/EX
were/VBD
several/JJ
limitations/NNS
to/TO
our/PRP$
study/NN
./.
====================
First/RB
,/,
no/DT
replications/NNS
were/VBD
performed/VBN
to/TO
validate/VB
our/PRP$
results/NNS
./.
====================
Because/IN
indicators/NNS
for/IN
measuring/VBG
BMD/NN
in/IN
men/NNS
tend/NN
to/TO
be/VB
narrow/JJ
,/,
recruiting/VBG
a/DT
sufficient/JJ
replication/NN
sample/NN
proved/VBD
challenging/VBG
./.
====================
Thus/RB
,/,
we/PRP
aimed/VBD
to/TO
use/VB
previously/RB
identified/VBN
genetic/JJ
markers/NNS
,/,
which/WDT
have/VBP
been/VBN
established/VBN
as/IN
valid/JJ
in/IN
our/PRP$
selected/VBN
ethnicity/NN
and/CC
gender/NN
./.
====================
Despite/IN
our/PRP$
efforts/NNS
,/,
BMD/NN
is/VBZ
a/DT
less/RBR
meaningful/JJ
factor/NN
of/IN
osteoporosis/NN
in/IN
men/NNS
than/IN
in/IN
women/NNS
./.
====================
Additionally/RB
,/,
we/PRP
could/MD
not/RB
consider/VB
all/DT
factors/NNS
,/,
including/VBG
sex/NN
,/,
age/NN
,/,
weight/NN
,/,
and/CC
menopausal/JJ
status/NN
,/,
owing/VBG
to/TO
using/VBG
only/RB
young/JJ
men/NNS
as/IN
our/PRP$
test/NN
subjects/NNS
./.
====================
Finally/RB
,/,
we/PRP
needed/VBD
a/DT
very/RB
large/JJ
sample/JJ
because/IN
phenotypic/JJ
variations/NNS
are/VBP
hard/VBN
to/TO
detect/VB
in/IN
homogenous/JJ
populations/NNS
./.
====================
However/RB
,/,
our/PRP$
sample/NN
size/NN
was/VBD
too/RB
small/JJ
to/TO
employ/VB
a/DT
Bonferroni/NNP
correction/NN
,/,
and/CC
we/PRP
were/VBD
forced/VBN
to/TO
set/VB
the/DT
significant/JJ
threshold/NN
as/IN
p/NN
</JJR
1/CD
×/NN
10-6/CD
,/,
thus/RB
increasing/VBG
the/DT
chance/NN
of/IN
false-positives/VBZ
./.
====================
To/TO
minimize/VB
statistical/JJ
error/NN
,/,
we/PRP
thoroughly/RB
analyzed/VBD
gene/NN
functions/NNS
and/CC
mechanisms/NNS
./.
====================
Nevertheless/RB
,/,
further/RBR
research/NN
is/VBZ
necessary/JJ
to/TO
validate/VB
our/PRP$
findings/NNS
./.
====================
In/IN
conclusion/NN
,/,
our/PRP$
study/NN
identified/VBD
novel/JJ
loci/NNS
correlated/VBD
with/IN
BMD/NN
at/IN
14q31.3/CD
,/,
15q25.1/NN
,/,
and/CC
4q31.1/NN
in/IN
Korean/JJ
men/NNS
./.
====================
Future/JJ
studies/NNS
should/MD
investigate/VB
these/DT
associations/NNS
and/CC
the/DT
underlying/VBG
genetic/JJ
mechanisms/NNS
./.
====================
Regional/JJ
plots/NNS
of/IN
genome/NN
wide/JJ
significant/JJ
associations/NNS
for/IN
bone/NN
mineral/JJ
density/NN
(/(
BMD/NN
)/)
,/,
adjusted/VBN
for/IN
age/NN
and/CC
body/NN
mass/NN
index/NN
./.
====================
(/(
A/NN
)/)
Regional/JJ
plot/NN
of/IN
significant/JJ
associated/VBN
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
with/IN
BMD/NN
at/IN
lumbar/JJ
spine/NN
in/IN
chromosome/NN
14/CD
./.
====================
(/(
B/NN
)/)
Regional/JJ
plot/NN
of/IN
significant/JJ
associated/VBN
SNPs/NNS
with/IN
BMD/NN
at/IN
lumbar/JJ
spine/NN
in/IN
chromosome/NN
15/CD
./.
====================
(/(
C/NN
)/)
Regional/JJ
plot/NN
of/IN
significant/JJ
associated/VBN
SNPs/NNS
with/IN
BMD/NN
at/IN
femur/JJ
total/JJ
in/IN
chromosome/NN
4/CD
./.
====================
Baseline/NN
characteristics/NNS
of/IN
study/NN
subjects/NNS
====================
Summary/JJ
of/IN
5/CD
SNPs/NNS
significantly/RB
associated/VBN
with/IN
bone/NN
mineral/JJ
density/NN
at/IN
lumbar/JJ
spine/NN
and/CC
femur/JJ
====================
Summary/JJ
of/IN
the/DT
association/NN
with/IN
previously/RB
identified/VBN
gene/NN
in/IN
Korean/JJ
men/NNS
====================
